It has been confirmed that Notch ligand Jagged1 was overexpressed in osteosarcoma (35), and activation of Notch signaling pathway will promote the occurrence, progression and metastasis of osteosarcoma (36–39), as well as to chemotherapy resistance (40, 41). This evidence concerns the gene JAG1 and osteosarcoma.